POF recognised as a leading Trade Mark Prosecution firm
August 6, 2020 Philips Ormonde Fitzpatrick are very pleased to announce that we’ve been recognised as a leading Trade Mark Prosecution firm by Asia IP in their 2020 Trade Mark Survey. This achievement is a great reflection of…
CSIRO launches Australia’s first accredited face mask testing facility
6 August 2020 CSIRO, Australia’s national science agency, has launched the nation’s first accredited surgical face mask testing facility in Melbourne today, to help frontline health workers in the fight against COVID-19, while supporting Australian business. The new…
Novavax Announces Positive Phase 1 Data for its COVID-19 Vaccine Candidate
6 August 2020 Novavax, Inc., a late-stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced Phase 1 data from its Phase 1/2 randomized, observer-blinded, placebo-controlled trial of its COVID‑19 vaccine with and without Matrix‑M™ adjuvant…
New Grant to Support ARMI Research in Understanding Blindness in Newborns
6 August 2020 A grant funded by the Angior Family Foundation has been awarded to ARMI to study Leber Congenital Amaurosis (LCA), a group of inherited retinal diseases that are the most common cause of blindness in newborn…
Iron study combats anaemia with cutting-edge computer simulation
6 August 2020 A new iron intervention study has determined which of the world’s low-and-middle income countries would benefit from using iron-containing micronutrient powders to tackle childhood anaemia. Using advanced computer simulation techniques, the study’s findings include individual…
4DMedical ASX Listing Set For 7 August 2020
6 August 2020 4DMedical Limited (“4DMedical” or the “Company”), a medical technology Company focused on commercialising its patented respiratory analysis technology, is pleased to announce it will list on the Australian Securities Exchange (ASX) on Friday 7 August.…
First of 2,000 NOTUS emergency ventilators delivered to national medical stockpile
4 August 2020 Grey Innovation is pleased to advise it has delivered to the national medical stockpile the first of 2,000 ventilators ordered just a few months ago. It comes at a time when hospitals in Melbourne are…
Starpharma DEP® docetaxel and gemcitabine combination trial commences
4 August 2020 Release date 30 July 2020 Starpharma today announced that it has commenced its DEP® docetaxel + gemcitabine combination study for patients with advanced cancers, including pancreatic cancer. Recruitment into the study has commenced at the…
Cynata Completes Phase 1 GvHD Clinical Trial Follow-up with Positive Results
4 August 2020 Release date 30 July 2020 Cynata Therapeutics Limited, a clinical-stage biotechnology company specialising in cell therapeutics, has today announced positive results from the two-year follow-up of patients enrolled in the Phase 1 clinical trial of…
Medical research grant recipients announced, including COVID-19 research fund grants
4 August 2020 The Victorian Government is backing cutting-edge medical research projects to better understand, prevent and treat coronavirus. Seven projects will benefit from the government’s $5.5 million COVID-19 Research Fund, which will support continued jobs growth in a sector…
EY 2020 Australian Insurtech Report: Partnering to Deliver Value at Scale
4 August 2020 The EY 2020 Australian insurtech ecosystem report shows insurtechs, insurers and service providers agree that the industry is driving value through insurtech, but there are several areas ripe for innovation. EY’s previous two reports found…
Stem cell project aims to better understand impact of COVID-19 on different organs
4 August 2020 Release date 30 July 2020 Researchers at the Murdoch Children’s Research Institute (MCRI), with other Melbourne-based partners, will use human stem cells to better understand the effects of COVID-19 on different organs after being…
